Vision RT Ltd:企業の戦略的SWOT分析

◆英語タイトル:Vision RT Ltd - Strategic SWOT Analysis Review
◆商品コード:SWOT20MY2705
◆発行会社(調査会社):GlobalData
◆発行日:2020年3月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥17,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥35,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥53,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Vision RT Ltd – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

Vision RT Ltd (Vision RT), a subsidiary of William Demant Invest A/S, develops motion management tools for the radiotherapy market and treatment centers. The company’s portfolio encompasses 3D imaging solution for patient setup and real time surveillance, solution for track patient’s breathing motion and synchronizing it with the CT scanner during 4DCT acquisition, solution facilitates real time, marker less tracking of patient’s respiratory motion, and a module that simplifies the process of stereotactic radiosurgery. It employs stereo vision technology to perceive the depth in 3D through the use of two cameras. Vision RT’s products are used in breast radiation therapy; stereotactic radiosurgery (SRS); stereotactic body radiation therapy (SBRT), treatment of sarcomas and other conditions. The company sells its products directly and also through a network of distributors in Europe, the Middle East and Africa, Asia Pacific and the Americas. Vision RT is headquartered in London, England, the UK.

Vision RT Ltd Key Recent Developments

Jul 14,2019: RaySearch and Vision RT announce strategic partnership

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Vision RT Ltd – Key Facts
Vision RT Ltd – Key Employees
Vision RT Ltd – Key Employee Biographies
Vision RT Ltd – Major Products and Services
Vision RT Ltd – History
Vision RT Ltd – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Vision RT Ltd – Business Description
Vision RT Ltd – SWOT Analysis
SWOT Analysis – Overview
Vision RT Ltd – Strengths
Vision RT Ltd – Weaknesses
Vision RT Ltd – Opportunities
Vision RT Ltd – Threats
Vision RT Ltd – Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
Vision RT Ltd, Medical Equipment, Deals By Year, 2014 to YTD 2020
Vision RT Ltd, Medical Equipment, Deals By Type, 2014 to YTD 2020
Vision RT Ltd, Recent Deals Summary
Section 4 – Company’s Recent Developments
Jul 14, 2019: RaySearch and Vision RT announce strategic partnership
Section 5 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Vision RT Ltd, Key Facts
Vision RT Ltd, Key Employees
Vision RT Ltd, Key Employee Biographies
Vision RT Ltd, Major Products and Services
Vision RT Ltd, History
Vision RT Ltd, Subsidiaries
Vision RT Ltd, Key Competitors
Vision RT Ltd, Medical Equipment, Deals By Year, 2014 to YTD 2020
Vision RT Ltd, Medical Equipment, Deals By Type, 2014 to YTD 2020
Vision RT Ltd, Recent Deals Summary

List of Figures
Vision RT Ltd, Medical Equipment, Deals By Year, 2014 to YTD 2020
Vision RT Ltd, Medical Equipment, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Vision RT Ltd:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Eternygen GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Eternygen GmbH (Eternygen) is a drug discovery company that offers research and development of innovative drugs for dietary-related metabolic diseases. The company’s product development portfolio includes novel small molecule inhibitors, developed against the sodium coupled citrate transport …
  • Citibank Berhad:企業の戦略的SWOT分析
    Citibank Berhad - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Credit Suisse Group AG:戦略・SWOT・企業財務分析
    Credit Suisse Group AG - Strategy, SWOT and Corporate Finance Report Summary Credit Suisse Group AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Viterra Inc.:企業のM&A・事業提携・投資動向
    Viterra Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Viterra Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Wells Fargo & Company:企業のM&A・事業提携・投資動向
    Wells Fargo & Company - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Wells Fargo & Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • NCC Ltd (NCC):企業の財務・戦略的SWOT分析
    NCC Ltd (NCC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Chromalloy Gas Turbine LLC:企業の戦略・SWOT・財務情報
    Chromalloy Gas Turbine LLC - Strategy, SWOT and Corporate Finance Report Summary Chromalloy Gas Turbine LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Synexus Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Synexus Ltd (Synexus), a subsidiary of Synexus Clinical Research Limited, is a site management organisation that offers patient recruitment and trial management services. The company services include feasibility assessment, project management, patient engagement, patient-centric clinical tri …
  • China Aviation Oil (Singapore) Corp Ltd (G92)
    China Aviation Oil (Singapore) Corp Ltd (G92) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • BPER Banca Spa:企業のM&A・事業提携・投資動向
    BPER Banca Spa - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's BPER Banca Spa Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • TESARO Inc (TSRO):製薬・医療:M&Aディール及び事業提携情報
    Summary TESARO Inc (TESARO) is an oncology-focused biopharmaceutical company that focuses on developing in-licensed, oncology-related product candidates and discovery of new candidates. It develops products using different approaches, comprising small molecules and immuno-oncology antibodies. The co …
  • Inner Mongolia Yili Industrial Group Co Ltd:企業の戦略・SWOT・財務情報
    Inner Mongolia Yili Industrial Group Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Inner Mongolia Yili Industrial Group Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • NetScout Systems Inc (NTCT):企業の財務・戦略的SWOT分析
    NetScout Systems Inc (NTCT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Medicamen Biotech Ltd (531146):企業の財務・戦略的SWOT分析
    Medicamen Biotech Ltd (531146) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Hexza Corp Bhd (HEXZA):企業の財務・戦略的SWOT分析
    Hexza Corp Bhd (HEXZA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Textron Systems Australia Pty Ltd:企業の戦略・SWOT・財務情報
    Textron Systems Australia Pty Ltd - Strategy, SWOT and Corporate Finance Report Summary Textron Systems Australia Pty Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Nordic Nanovector ASA (NANO):製薬・医療:M&Aディール及び事業提携情報
    Summary Nordic Nanovector ASA (Nordic Nanovector), formerly Nordic Nanovector AS is a developer and commercializer of antibody radionuclide conjugates for the treatment of haematological cancers. The company’s lead product candidate includes Betalutin, an antibody radionuclide conjugate developed fo …
  • OncoTartis Inc-製薬・医療分野:企業M&A・提携分析
    Summary OncoTartis Inc (OncoTartis) is a biotechnology company with a focus on development of various treatments for various types of cancers. Its lead candidate OT-82, an orally available NicotinAMide Phosphoribosyl Transferase inhibitor, is being developed for treating broad range of leukemias and …
  • ImmusanT Inc-医療機器分野:企業M&A・提携分析
    Summary ImmusanT Inc (ImmusanT) is a drug company that discovers and develops therapies for celiac disease. The company’s pipeline products include Nexvax 2 and Nexvax 3. Its pipeline product Nexvax 2 is used for treating, preventing and diagnosing celiac disease. ImmusanT’s pipeline products are al …
  • Marubeni Corporation:企業の戦略・SWOT・財務情報
    Marubeni Corporation - Strategy, SWOT and Corporate Finance Report Summary Marubeni Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆